Free press releases distribution network?

Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



India and China Key Manufacturing Hubs for Generic Drugs – 'What Does This Mean to the $700 Million High-purity Water Treatment Equipment Market?' - CAGR of 16.5 per cent Projected for the Asian Market for Water and Wastewater Treatment in the Pharmaceutical Industry
India and China Key Manufacturing Hubs for Generic Drugs – 'What Does This Mean to the $700 Million High-purity Water Treatment Equipment Market?'

 

PRZOOM - /newswire/ - London, United Kingdom, 2011/06/21 - CAGR of 16.5 per cent Projected for the Asian Market for Water and Wastewater Treatment in the Pharmaceutical Industry.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

North America and Europe have traditionally been the major pharmaceutical producers. However, in recent years, because of increased demand from local population and low production costs, new markets, such as India, China, Brazil and Russia, among others, have emerged.

The growing pharmaceutical infrastructure in these emerging markets is spurring the demand for high-purity water systems, creating opportunity for water management companies. In addition, many developed and developing nations are imposing stringent effluent standards on the wastewater discharged from drug manufacturing facilities in order to prevent contamination of water streams.

New analysis from Frost & Sullivan (environmental.frost.com), Global Water Market Outlook: Strategic Analysis of Water and Wastewater Management in the Pharmaceutical Industry, finds that the market for water and wastewater treatment equipment in the pharmaceutical industry earned revenues of $0.69 billion in 2010 and estimates this to reach $1.25 billion in 2017.

"The most important factor driving growth is the emergence of Asian countries such as India and China as key manufacturing hubs for generic drugs and APIs," notes a Senior Research Analyst of Frost & Sullivan. "India has over 100 FDA approved drug manufacturing facilities - the highest for any country outside USA."

The Asian market for water and wastewater treatment equipment in the pharmaceutical industry is expected to grow at a compound annual growth rate of 16.5 per cent from 2010 to 2017. Pharmaceutical companies in North America and Europe are outsourcing certain portions of the drug production process to Asian countries and are keen to focus more on research and drug development. This move could reduce the number of pharmaceutical production facilities in these regions in the future.

"In North America and Europe, the replacement and refurbishment segment are anticipated to offer more potential," remarks the Senior Research Analyst. "With many countries in these regions outsourcing their operations to Asian countries the water and wastewater treatment equipment market in these regions is expected to grow at the rate of around 5-6% annually."

In North America and Europe, effluent discharge standards for pharmaceutical production facilities are set to become more stringent in the future.

"Strict effluent discharge standards will force pharmaceutical production facilities to adopt advanced treatment technologies and also focus on sustainable technologies that would facilitate the generation of energy from their wastewater," concludes the Frost & Sullivan analyst. "This would enable them to reduce the operational costs associated with wastewater treatment plants."

If you are interested in more information on this study, please send an email with your contact details to Chiara Carella, Corporate Communications, at chiara.carella[.]frost.com.

Global Water Market Outlook: Strategic Analysis of Water and Wastewater Management in the Pharmaceutical Industry is part of the Environmental Growth Partnership Services programme, which also includes research in the following markets: Global Water Market Outlook: Strategic Analysis of Water and Wastewater Management in the Power Industry, Growth Opportunities in the Polish Waste Management Market, Western European Water and Wastewater Utilities Market and European Waste Recycling Market, among others. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.

About Frost & Sullivan
Frost & Sullivan (frost.com), the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 40 offices on six continents.

Global Water Market Outlook: Strategic Analysis of Water and Wastewater Management in the Pharmaceutical Industry / M686

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


India and China Key Manufacturing Hubs for Generic Drugs – 'What Does This Mean to the $700 Million High-purity Water Treatment Equipment Market?'

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Frost & Sullivan |
Contact: Chiara Carella 
+44 (0) 20 7343 8314 chiara.carella[.]frost.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Frost & Sullivan / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology
Ipsen Completes Acquisition of ONIVYDE® (irinotecan liposome injection) and Additional Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Breakthrough Therapy Designation for Rituxan® (Rituximab) in Pemphigus Vulgaris
MDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom
Greenphire Drives Global Site Adoption of Clinical Trial Payment Solutions
Ipsen Announces MHRA Approval of New Indication for Decapeptyl® for the Treatment of Pre-menopausal Women with Early Stage Breast Cancer

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  Deb Sheppard - Medium Psychic Author Speaker

Visit  BizJobs.com

Visit  JobsWare.com







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today